Author:
McCall David,Abuasab Tareq,Rodriguez-Sevilla Juan Jose,Mohamed Shehab Fareed,Patnaik Anish,Devireddy Kirthi,Arani Naszrin,Sheikh Irtiza,Jamshidi Raehannah,Gibson Amber,Roth Michael,Nuñez Cesar,Garcia Miriam,Chien Kelly S.,Loghavi Sanam,Pierce Sherry A.,Sasaki Koji,Issa Ghayas,Cuglievan Branko,Kantarjian Hagop,Garcia-Manero Guillermo
Funder
The University of Texas MD Anderson Cancer Center
Reference39 articles.
1. Myelodysplastic syndrome in children and adolescents;Niemeyer;Semin. Hematol.,2008
2. Pediatric myelodysplastic syndromes;Hofmann;J. Hematop.,2015
3. Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes;Nösslinger;Ann. Oncol.,2010
4. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system;Aul;Leukemia,1992
5. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases;Morel;Leukemia,1993